INTRODUCTION {#S1}
============

*Vibrio cholerae* may have played an influential role in shaping the human genome. Historical documents describe a dehydrating diarrheal disease consistent with cholera as long ago as the 7^th^ century, and seven pandemics with high rates of associated mortality have swept the globe in the last three centuries. Individuals with blood group O are at increased risk of severe cholera [@R1], and it has been hypothesized that *V. cholerae* infection may have selected for the low prevalence of the O blood group in the Ganges Delta region, a historic and current epicenter of cholera. [@R2]

In a family-based study of cholera in Bangladesh, we have recently demonstrated that individuals who are first-degree relatives of an index patient with cholera have significantly greater odds of being infected with *V. cholerae* compared to unrelated or less closely related contacts, when living in the same household. This finding was independent of blood group phenotype in a multivariate analysis. [@R3]

To begin to evaluate host genetic factors influencing susceptibility to cholera, we performed a family-based candidate gene association study in a cohort of individuals living in a cholera-endemic area of Bangladesh. We selected five candidate genes based on biologically plausible associations with *V. cholerae* infection. First, we included the cystic fibrosis transmembrane receptor (CFTR), since cholera has been speculated to be the selective pressure for the cystic fibrosis trait. [@R4],[@R5] A recently-completed microarray-based study of duodenal biopsies of cholera patients from Bangladesh revealed increased expression of a number of innate immune effectors, compared to healthy control subjects. [@R6] We therefore included the two most highly upregulated genes identified in this study, lactoferrin (LTF) and long palate, lung and nasal epithelium clone 1 (LPLUNC1), as well as a nuclear steroid receptor that regulates lactoferrin production, estrogen related receptor alpha (ESRRA). Lastly, we included calcium activated chloride channel 1 (CLCA), which was detected in high levels in a proteomic evaluation of human cholera stools (unpublished data).

RESULTS {#S2}
=======

Characteristics of the study population {#S3}
---------------------------------------

The study population is comprised of index cases with cholera and their family members, all of whom share household and cooking facilities. Index cases presented to the Dhaka hospital of the International Centre for Diarrhoeal Disease Research in Bangladesh (ICDDR,B) between January 2004 and November 2005. A diagnosis of cholera in an index case was made by the presence of acute watery diarrhea and a stool culture positive for *V. cholerae*. Family members of the index case were defined as affected with cholera if they had a positive rectal swab culture for *V. cholerae* or symptoms of diarrhea during 21 days of follow up. For this analysis, the index cases and affected relatives were classified as affected, and all others were classified as unaffected.

Two hundred seventy-seven individuals in 76 pedigrees were included in the study. In two-thirds of the pedigrees, the index case was a child. 73 pedigrees were nuclear families; 3 pedigrees additionally contained grandparents or grandchildren. [Table 1](#T1){ref-type="table"} shows the structure of the families included in the association study, categorized by the number of affected children per family.

[Table 2](#T2){ref-type="table"} shows the clinical features of the index cases as well as of the affected and unaffected relatives. The mean ages differed between unaffected relatives (26 ± 15 years), affected relatives (20 ± 14.5 years) and index cases (18.7 ± 14.5 years). The higher age among unaffected relatives likely reflects immunity acquired with age among individuals living in an endemic setting. Consistent with pre-existing immunity, there was a trend toward higher vibriocidal titers (representing antibodies directed at the whole organism) in unaffected individuals. As expected, the index cases and affected relatives were non-significantly enriched for blood group O, a previously identified risk factor for severe cholera.

Family-based association analysis of SNPs in five candidate genes with cholera {#S4}
------------------------------------------------------------------------------

We evaluated SNPs in five candidate genes \-- CLCA, CFTR, ESRRA, LTF and LPLUNC1 \-- for an association with cholera in the 76 pedigrees. As outlined in [Table 3](#T3){ref-type="table"}, a total of 145 SNPs in the five genes passed quality control and were included in the analysis.

We performed transmission disequilibrium testing on SNPs in each of the five candidate genes, using Haploview version 4.1. [Supplemental Table 1](#SD1){ref-type="supplementary-material"} contains the results of TDT testing for all SNPs. [Table 4](#T4){ref-type="table"} shows the SNPs that were associated with cholera with a nominal p value \<0.05. One variant in a coding region of ESRRA, 2 variants in different regions of the CFTR gene, and 9 variants in LPLUNC1, primarily in the promoter region, were associated with cholera. Following permutation testing, only rs11906665, a variant in the promoter region of LPLUNC1, remained significantly associated with cholera. In particular, transmission of the A allele was associated with cholera.

The FBAT statistical package extends the methodology of transmission disequilibrium testing to evaluate nuclear families that include both affected and unaffected offspring, and it also allows for missing parental data. Because of the varying affection status and family structure of these pedigrees, we performed focused association testing of the SNPs outlined in [Table 4](#T4){ref-type="table"} using FBAT. Bi-allelic testing with an additive model was performed. The FBAT results, shown in [Table 5](#T5){ref-type="table"}, confirm the findings from TDT testing. The most highly associated SNP by FBAT was rs11906665 in LPLUNC1 (p = 0.0019).

Haplotype-specific association analysis of LPLUNC {#S5}
-------------------------------------------------

We performed a haplotype-based association analysis for SNPs in the candidate genes. Linkage disequilibrium (LD) between SNPs was inspected using Haploview, with haplotypes defined by solid spine of LD (D' \> 0.9). Common haplotypes with frequencies \> 5% were observed in blocks for each candidate gene. After permutation testing was applied, no haplotype blocks, as defined by a D' \> 0.9, were significantly associated with cholera for any of the candidate genes (data not presented).

Because we observed the strongest association with a variant in LPLUNC1 (rs11906665), we additionally evaluated a 3 kb block comprised of rs17124508, rs11906665, rs1884884, rs17307318 and rs8115852, defined by a D' of 1.0. [Figure 1](#F1){ref-type="fig"} shows this block, which is located in the 5′ promoter region of LPLUNC1. [Table 1](#T1){ref-type="table"} shows the haplotype frequencies and the results of transmission disequilibrium testing for this block. Two haplotypes that differed only by the alleles of rs11906665 were significantly associated with cholera after permutation testing (p = 0.001 and p = 0.012).

DISCUSSION {#S6}
==========

Substantial observational evidence has suggested that human genetic factors may influence susceptibility to *V. cholerae* infection. To date, no specific genetic association studies have been performed in cholera patients, although individuals with blood group O have been observed to be at higher risk of severe disease than those of other blood groups. [@R1] In this study, we used a family-based cohort in an endemic area to investigate the association between cholera and SNPs in five candidate genes.We found a variant in the promoter region of LPLUNC1 to be significantly associated with cholera. This association was robust and was identified using two family-based tests, the TDT and FBAT.

LPLUNC1 is a member of a family of evolutionarily conserved innate immunity proteins that have been best studied in the palate, lung and nasal epithelium. The short palate, lung and nasal epithelium clone 1 protein (SPLUNC1), a close relative of LPLUNC1, has been shown to inhibit growth of *Pseudomonas aeruginosa* in vitro and to bind to lipopolysaccharide of the organism. [@R7] A recent whole-genome microarray screen of gene expression in the duodenal mucosa of patients with cholera revealed LPLUNC1 to be greater than 7-fold more highly expressed during the acute phase of infection than during the convalescent phase [@R6]; these findings were further confirmed by RT-PCR. This microarray study revealed a novel association between LPLUNC1 and cholera and generated the biological underpinnings to support the study of LPLUNC1 as a candidate gene for susceptibility to cholera.

The study of the role of host genetics in susceptibility to enteric infections is in its infancy. Immune response genes, particularly those in the HLA locus, have been the most frequently identified host susceptibility factors. [@R8] In a study of North American travelers to Mexico, a variant in exon 15 of lactoferrin was found to be associated with travelers' diarrhea. [@R9] Similar to LPLUNC1, lactoferrin is a component of the innate immune system that has antimicrobial and immunoregulatory properties. Taken together with the present results, this finding indicates that further studies of the relationship between variants in host innate immunity genes and the outcome of exposure to enteric organisms may be productive.

The variant in LPLUNC1 that we identified as associated with cholera, rs11906665, may not be the causal variant. Our haplotype analysis revealed a haplotype containing rs11906665 to be more significantly associated with cholera than the variant itself. The variant is located in the promoter region of the gene, and comparative sequence data indicate that this is not a conserved region of the genome across mammals (<http://genome.ucsc.edu/>). A sequence comparison with the rhesus monkey indicates that the G allele is the ancestral allele at this locus (<http://genome.ucsc.edu/>). Further genotyping data may help shed light on variants that are in linkage disequilibrium with rs11906665.

Our study has strengths and limitations. The study population was comprised of nuclear families sharing water, cooking and hygiene facilities; thus, all individuals within the household were highly likely to have been exposed to *V. cholerae* along with the index case. By prospectively following family members for three weeks following the presentation of the case, we were able to obtain accurate phenotype information on these individuals for the current exposure. Nevertheless, individuals who were classified as unaffected for this analysis may have been infected with *V. cholerae* in the past; such misclassification may have limited the power of our analysis. Although we were able to detect evidence of an association between cholera and LPLUNC1, we cannot exclude additional effects of the four other genes evaluated. Validation of the association with LPLUNC1 should be carried out in other populations with exposure to *V. cholerae*, and further biological data delineating the mechanism of the observed association between LPLUNC1 and cholera are needed. As it is likely that more than one host genetic factor might contribute to susceptibility to cholera, a genome-wide search for additional associated loci is planned, with the aim of identifying other chromosomal regions related to this important global disease.

MATERIALS AND METHODS {#S7}
=====================

Study subjects {#S8}
--------------

Samples were collected as part of a household-based prospective observational study aimed at identifying immunologic and host factors associated with the risk of cholera in an endemic setting. The study design has been described previously. [@R3], [@R10] Briefly, index cases presenting to the ICDDR,B hospital with severe acute watery diarrhea were eligible for inclusion if their stool cultures were subsequently positive for *V. cholerae*, if they were older than 6 months, and if they were without significant comorbid conditions. All index cases included in this analysis were infected with *V. cholerae* O1 El Tor. Upon presentation of the index case, a field team discussed enrollment with family members sharing a household with the index case, and consenting individuals were enrolled into the study immediately upon culture confirmation of the index case. Enrollment of family members typically occurred within 24 hours of presentation of the index case. All enrolled family members shared the same household and cooking pot as the index cases for at least the three preceding days. Blood specimens were collected from index cases and consenting relatives upon enrollment and over the course of follow-up. The field team visited households on each of the next six days, and again on days 14 and 21. During these visits, relatives were questioned about diarrheal symptoms, and rectal swabs were obtained for *V. cholerae* culture. Diarrhea was defined as 3 or more loose stools within a 24 hour period. Among relatives in this study, cholera was defined as a positive rectal swab culture for *V. cholerae* or symptoms of diarrhea during the 21 days of follow up.

Informed consent for participation in this research was obtained from participants or their guardians. The human experimentation guidelines of the U.S. Department of Health and Human Services were followed in the conduct of this research. Approval for this human study was obtained from the Institutional Review Board of the Massachusetts General Hospital and the Research and the Ethical Review Committees of the ICDDR,B.

DNA extraction {#S9}
--------------

Peripheral blood mononuclear cells were isolated from venous blood by gradient centrifugation on Ficoll-Isopaque (Pharmacia, Uppsala, Sweden). Cells were transferred to a cell lysis solution, and DNA was extracted according to the manufacturer's protocol, including treatment with RNAse A (Gentra Puregene, Qiagen, Valencia, California). DNA concentration was determined by spectrophotometry.

Genotyping {#S10}
----------

Five genes were selected for inclusion in the candidate gene association study. SNPs located within these genes or within 10 kilobases in either direction from the gene were selected using data from dbSNP (<http://www.ncbi.nlm.nih.gov/projects/SNP/>). Selection focused on the inclusion of validated, coding and tagging SNPs (Tagger). [@R11] Genotyping for selected SNPs was performed using the iPlex Gold genotyping system (Sequonom, Newton, Massachusetts). Primers for each evaluated SNP were designed using PrimerExpress (Applied Biosystems, Foster City, California) and checked using Sequonom RealSNP Assay Design software (Sequonom, Newton, Massachusetts). Genotyping was performed on the study subjects as well as on a plate of individuals from the Caucasian (CEU) population of the International HapMap Project for validation. Only SNPs with genotyping percentages ≥ 90% in the CEU and study populations, as well as minor allele frequencies ≥ 0.01 and Hardy-Weinberg p-values ≥ 0.01 in the study population, were included in the analysis. Any marker genotype inconsistencies were evaluated and the genotypes were zeroed for those select pedigrees.

Statistical analyses {#S11}
--------------------

Quality assessment of the genotyping results was performed using Haploview version 4.1. [@R12] Transmission disequilibrium testing was performed with Haploview version 4.1. Familial-based association testing was performed using the FBAT statistical package version 2.0.2c (<http://www.biostat.harvard.edu/~fbat/default.html>). Haplotypes were estimated using an E-M algorithm in Haploview version 4.1; haplotype blocks were defined using a solid spine of linkage disequilibrium (D' \> 0.9) unless otherwise indicated. Permutation testing was done within Haploview using 100,000 permutations for single markers and haplotypes; both nominal and empirical p-values are reported. Descriptive statistics were performed using SPSS version 10.1. Continuous variables were compared using one-way ANOVA and dichotomous variables were compared by two-sided Pearson ChiSquare.

Supplementary Material {#SM}
======================

###### 

Supplemental Table 1: Results of transmission disequilibrium testing for all SNPs in candidate genes
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###### Structure of families included in the association study, categorized by the number of affected children in the family [\*](#TFN1){ref-type="table-fn"}

  Number of affected children   Number of families   With 2 parents genotyped   With 1 parent genotyped   Number of healthy siblings
  ----------------------------- -------------------- -------------------------- ------------------------- ----------------------------
  **0**                         12                   10                         2                         16
  **1**                         37                   30                         5                         16
  **2**                         21                   14                         4                         21
  **3**                         4                    3                          1                         1
  **4**                         2                    1                          0                         4
  **Total:**                    76                   58                         12                        58

Only the nuclear families from 3 multigenerational pedigrees were included

###### Clinical characteristics of cholera index cases and their affected and unaffected relatives [\*](#TFN2){ref-type="table-fn"}

                                                                    Index Cases (n= 71)   Affected relatives (n= 95)   Unaffected relatives (n =107)   P value [\*\*\*](#TFN4){ref-type="table-fn"}
  ----------------------------------------------------------------- --------------------- ---------------------------- ------------------------------- ----------------------------------------------
  **Age (years)** [\*\*](#TFN3){ref-type="table-fn"}                18.7 ± 14.5           20.0 ± 14.5                  26.0 ± 15.0                     0.001
  **Male gender**                                                   35 (49%)              43 (45%)                     53 (50%)                        0.805
  **Vibriocidal Titer, Day 2** [\*\*](#TFN3){ref-type="table-fn"}   304 ± 732             516 ± 1163                   785 ± 2725                      0.239
  **Blood Group O**                                                 28 (39%)              37 (39%)                     34 (32%)                        0.464

Table excludes 4 relatives with unknown affected status

Mean ± S.D.

Continuous variables were compared using one-way ANOVA and dichotomous variables were compared by two-sided Pearson Chi Square

###### Candidate genes evaluated

  Gene                                                       Chromosome   Number of SNPs that passed quality control
  ---------------------------------------------------------- ------------ --------------------------------------------
  Calcium-activated chloride channel (CLCA)                  1p31         47
  Cystic fibrosis transmembrane receptor (CFTR)              7q31         31
  Estrogen-related receptor alpha (ESRRA)                    11q13        9
  Lactoferrin (LTF)                                          3q21         41
  Long palate, lung and nasal epithelium clone 1 (LPLUNC1)   20q11        17

###### Results of transmission disequilibrium testing for SNPs with nominal p\<0.05

  Gene      SNP          Role       Overtransmitted allele (other allele)   Minor allele frequency genotyped (minor allele)   Number of fully genotyped trios   Transmission: non-transmissions to affected offspring   Chi Square   Nominal p value   Permutation p value [\*](#TFN5){ref-type="table-fn"}
  --------- ------------ ---------- --------------------------------------- ------------------------------------------------- --------------------------------- ------------------------------------------------------- ------------ ----------------- ------------------------------------------------------
  ESRRA     rs2276014    Coding     C (T)                                   0.09 (T)                                          52                                19:6                                                    6.76         0.0093            0.0575
  CFTR      rs1800130    Coding     A (G)                                   0.051 (G)                                         53                                8:1                                                     5.444        0.0196            0.3451
  CFTR      rs713134     Promoter   C (T)                                   0.413 (C)                                         52                                36:19                                                   5.255        0.0219            0.3703
  LPLUNC1   rs11906665   Promoter   A (G)                                   0.076 (G)                                         51                                16:1                                                    13.235       0.0003            **0.0062**
  LPLUNC1   rs6057807    Promoter   C (T)                                   0.04 (T)                                          56                                12:2                                                    7.143        0.0075            0.2106
  LPLUNC1   rs8118559    Promoter   C (T)                                   0.03 (T)                                          53                                11:2                                                    6.231        0.0126            0.3393
  LPLUNC1   rs8118144    Promoter   G (A)                                   0.03 (A)                                          57                                12:3                                                    5.4          0.0201            0.4677
  LPLUNC1   rs17124508   Promoter   T (G)                                   0.03 (G)                                          57                                12:3                                                    5.4          0.0201            0.4677
  LPLUNC1   rs17307318   Promoter   A (G)                                   0.03 (G)                                          57                                12:3                                                    5.4          0.0201            0.4677
  LPLUNC1   rs6057810    Promoter   T (C)                                   0.03 (C)                                          56                                12:3                                                    5.4          0.0201            0.4677
  LPLUNC1   rs4398335    Intron     G (A)                                   0.03 (A)                                          56                                12:3                                                    5.4          0.0201            0.4677
  LPLUNC1   rs8115852    Promoter   G (T)                                   0.02 (T)                                          55                                10:2                                                    5.333        0.0209            0.4809

Results of 100,000 cycles of permutation testing performed in Haploview v. 4.1

###### Results of FBAT testing for selected SNPs in candidate genes

  Gene      SNP          Allele   Minor allele frequency (minor allele)   Number of informative families   S-E(S)   Var(S)   Z' value   P value
  --------- ------------ -------- --------------------------------------- -------------------------------- -------- -------- ---------- ---------
  ESRRA     rs2276014    C        0.079 (T)                               18                               5.881    7.795    2.106      0.035
  CFTR      rs1800130    A        0.045 (G)                               7                                5.5      4.25     2.668      0.0076
  CFTR      rs713134     C        0.441(C)                                38                               11.286   16.641   2.767      0.0057
  LPLUNC1   rs11906665   A        0.055 (G)                               16                               7.167    5.306    3.111      0.0019
  LPLUNC1   rs6057807    C        0.029 (T)                               8                                5.5      3.75     2.84       0.0045
  LPLUNC1   rs8118559    C        0.025 (T)                               5                                5        3.5      2.673      0.0076
  LPLUNC1   rs8118144    G        0.028 (A)                               8                                5        4        2.5        0.012
  LPLUNC1   rs17124508   T        0.03 (G)                                8                                5        4        2.5        0.012
  LPLUNC1   rs17307318   A        0.03 (G)                                8                                5        4        2.5        0.012
  LPLUNC1   rs6057810    T        0.03 (C)                                8                                5        4        2.5        0.012
  LPLUNC1   rs4398335    G        0.03 (A)                                8                                5        4        2.5        0.012
  LPLUNC1   rs8115852    G        0.02 (T)                                5                                4        3        2.309      0.021

###### Results of transmission disequilibrium testing for a haplotype block in LPLUNC1

  Haplotype   Frequency   Transmission: non-transmissions to affected offspring   Chi Square   Nominal p value   Permutation p value [\*](#TFN6){ref-type="table-fn"}
  ----------- ----------- ------------------------------------------------------- ------------ ----------------- ------------------------------------------------------
  TAGAG       0.847       32.8 : 10.8                                             11.108       0.0009            0.001
  TGGAG       0.075       4.1 : 17.1                                              7.963        0.0048            0.012
  TAAAG       0.047       5.0 : 5.0                                               0            1                 1
  GAGGT       0.026       2.8 : 11.7                                              5.381        0.0204            0.068

Results of 100,000 cycles of permutation testing performed in Haploview v. 4.1
